Standard BioTools Inc.
Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $0.54
- 52-Week Range
- $0.39 – $1.72
- Market Cap
- $225.03M
- P/E (TTM)
- —
- EPS (TTM)
- -0.09
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 0.40
- PEG Ratio
- —
- Return on Equity
- -7.79%
- Return on Assets
- -5.03%
- Gross Margin
- 52.18%
- Operating Margin
- -55.98%
- Profit Margin
- 157.62%
- Current Ratio
- 9.75
- Debt/Equity
- 0.05
- Total Debt
- $26.83M
- Free Cash Flow
- $179.64M
- Revenue Growth
- -0.90%
- Earnings Growth
- —
- Enterprise Value
- $-209.25M
Market Snapshot
About
Standard BioTools Inc. develops and commercializes technologies for life sciences research and clinical diagnostics. The company's platforms enable high-throughput genomics, proteomics, and single-cell analysis applications used in drug discovery, translational research, and precision medicine. Standard BioTools serves academic, government, pharmaceutical, biotechnology, and clinical laboratories with integrated systems and consumables for multi-omics analysis.